//
From M&A to organizational transformation: How pharma and biotech firms can drive growth from within
The pharmaceuticals and biotechnology sector is in a uniquely challenging situation. Having previously relied on mergers and acquisitions to fill portfolio gaps, fuel innovation and drive growth, a changing landscape means proposed M&As are under heavy scrutiny.
This highlights a new opportunity for pharmaceutical and biotech firms: to refocus on driving growth from the inside.
A “purpose with teeth” will help businesses to stand out and attract the like-minded talent and partners they need to grow.
After years of M&A, pharmaceutical and biotech firms have lost sight of the potential of their corporate brand – it's time to bring it back.
Build a unified culture where everyone is pulling in the same direction through a shared purpose.